JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Setting

Order Through VWR & Receive a FREE Sample

Support: [email protected]

Track Your Order

Home
Bioactive Compounds
Signaling Pathways

Signaling Pathways

A4304 Rosiglitazone
4 Citation

Summary: Potent PPARγ agonist

insoluble in EtOH; insoluble in H2O; ≥17.85 mg/mL
A4357 Dorzolamide HCl

Summary: Carbonic anhydrase inhibitor

insoluble in EtOH; ≥13 mg/mL
A4371 Ferrostatin-1 (Fer-1)
57 Citation

Target: Ferroptosis

Summary: ferroptosis inhibitor

≥149 mg/mL
A4393 Paclitaxel (Taxol)
27 Citation

Target: Microtubules/Tubulins

Summary: microtubule depolymerization inhibitor

≥85.6 mg/mL
A3151 Alarelin Acetate

Summary: Synthetic GnRH agonist

≥128.7 mg/mL
A3195 Asunaprevir (BMS-650032)
5 Citation

Summary: NS3 protease inhibitor

≥37.41 mg/mL
A3440 Glyoxalase I inhibitor

Target: Glyoxalase I

Summary: Glyoxalase I inhibitor

Soluble in DMSO
A3472 Hoechst 33342
12 Citation

Summary: Hoechst 33342

insoluble in EtOH; ≥28.7 mg/mL
A3828 Sobetirome
1 Citation

Summary: Agonist of tyroid hormone receptor

≥32.8 mg/mL
A3899 UK-5099
1 Citation

Target: Monocarboxylate transporters (MCTs)|mitochondrial pyruvate carrier (MPC)

Summary: MCTs and MPC inhibitor

insoluble in EtOH; insoluble in H2O; ≥28.8 mg/mL